Lasting effects of nicotine treatment and withdrawal on serotonergic systems and cell signaling in rat brain regions: Separate or sequential exposure during fetal development and adulthood

Brain Research Bulletin

Volumn 73, Issue 4-6, 2007, Pages 259-272

  Slotkin, Theodore A ^a   Ryde, Ian T ^a   Tate, Charlotte A ^a   Seidler, Frederic J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adenylyl cyclase; Brain development; Nicotine; Serotonin receptors; Sex differences

Indexed keywords

ADENYLATE CYCLASE; NICOTINE; SEROTONIN RECEPTOR; SEROTONIN TRANSPORTER;

ADULTHOOD; ANIMAL EXPERIMENT; ARTICLE; BRAIN; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FETUS DEVELOPMENT; HOMEOSTASIS; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; SENSITIZATION; SEROTONINERGIC SYSTEM; SEX DIFFERENCE; SIGNAL TRANSDUCTION; SMOKING;

ADENYLATE CYCLASE; ADOLESCENT; ADULT; AGE FACTORS; ANIMALS; BIOLOGICAL MARKERS; BRAIN; FEMALE; HUMANS; MALE; NICOTINE; NICOTINIC AGONISTS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; SEROTONIN; SIGNAL TRANSDUCTION; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 34249935152     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2007.03.012     Document Type: Article

References (83)

1. Abreu-Villaça Y., Seidler F.J., Qiao D., Tate C.A., Cousins M.M., Thillai I., and Slotkin T.A. Short-term adolescent nicotine exposure has immediate and persistent effects on cholinergic systems: critical periods, patterns of exposure, dose thresholds. Neuropsychopharmacology 28 (2003) 1935-1949
2. Abreu-Villaça Y., Seidler F.J., and Slotkin T.A. Impact of adolescent nicotine exposure on adenylyl cyclase-mediated cell signaling: enzyme induction, neurotransmitter-specific effects, regional selectivities, and the role of withdrawal. Brain Res. 988 (2003) 164-172
3. Abreu-Villaça Y., Seidler F.J., and Slotkin T.A. Does prenatal nicotine sensitize the brain to nicotine-induced neurotoxicity in adolescence?. Neuropsychopharmacology 29 (2004) 1440-1450
4. Abreu-Villaça Y., Seidler F.J., Tate C.A., Cousins M.M., and Slotkin T.A. Prenatal nicotine exposure alters the response to nicotine administration in adolescence: effects on cholinergic systems during exposure and withdrawal. Neuropsychopharmacology 29 (2004) 879-890
5. Abreu-Villaça Y., Seidler F.J., Tate C.A., and Slotkin T.A. Nicotine is a neurotoxin in the adolescent brain critical periods patterns of exposure regional selectivity dose thresholds for macromolecular alterations. Brain Res. 979 (2003) 114-128
6. Aldridge J.E., Seidler F.J., Meyer A., Thillai I., and Slotkin T.A. Serotonergic systems targeted by developmental exposure to chlorpyrifos: effects during different critical periods. Environ. Health Perspect. 111 (2003) 1736-1743
7. Aldridge J.E., Seidler F.J., and Slotkin T.A. Developmental exposure to chlorpyrifos elicits sex-selective alterations of serotonergic synaptic function in adulthood: critical periods and regional selectivity for effects on the serotonin transporter, receptor subtypes, and cell signaling. Environ. Health Perspect. 112 (2004) 148-155
8. Arango V., Underwood M.D., Boldrini M., Tamir H., Kassir S.A., Hsiung S., Chen J.J., and Mann J.J. Serotonin-1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims. Neuropsychopharmacology 25 (2001) 892-903
9. Barnes N.M., and Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 38 (1999) 1083-1152
10. Chow F.A., Seidler F.J., McCook E.C., and Slotkin T.A. Adolescent nicotine exposure alters cardiac autonomic responsiveness: β-adrenergic and m2-muscarinic receptors and their linkage to adenylyl cyclase. Brain Res. 878 (2000) 119-126
11. Colby S.M., Tiffany S.T., Shiffman S., and Niaura R.S. Are adolescent smokers dependent on nicotine? A review of the evidence. Drug Alcohol Depend. 59 (2000) S83-S95
12. Collins S.L., Wade D., Ledon J., and Izenwasser S. Neurochemical alterations produced by daily nicotine exposure in periadolescent vs. adult male rats. Eur. J. Pharmacol. 502 (2004) 75-85
13. DiFranza J.R., Rigotti N.A., McNeill A.D., Ockene J.K., Savageau J.A., Cyr D.St., and Coleman M. Initial symptoms of nicotine dependence in adolescents. Tobacco Control 9 (2000) 313-319
14. DiFranza J.R., Savageau J.A., Fletcher K., Ockene J.K., Rigotti N.A., McNeill A.D., Coleman M., and Wood C. Measuring the loss of autonomy over nicotine use in adolescents: the DANDY (development and assessment of nicotine dependence in youths) study. Arch. Pediatr. Adolesc. Med. 156 (2002) 397-403
15. DiFranza J., Savageau J.A., Rigotti N.A., Fletcher K., Ockene J.K., McNeill A.D., Coleman M., and Wood C. Development of symptoms of tobacco dependence in youths: 30-month follow-up data from the DANDY study. Tobacco Control 11 (2002) 228-235
16. DiFranza J.R., and Wellman R.J. A sensitization-homeostasis model of nicotine craving, withdrawal, and tolerance: integrating the clinical and basic science literature. Nicotine Tobacco Res. 7 (2005) 9-26
17. 1A receptors in discrete regions of the circadian timing system in hamsters. Brain Res. 829 (1999) 39-45
18. Elliott B.M., Faraday M.M., Phillips J.M., and Grunberg N.E. Adolescent and adult female rats differ in sensitivity to nicotine's activity effects. Pharmacol. Biochem. Behav. 80 (2005) 567-575
19. Ernst M., Moolchan E.T., and Robinson M.L. Behavioral and neural consequences of prenatal exposure to nicotine. J. Am. Acad. Child Adolesc. Psych. 40 (2001) 630-641
20. Faraday M.M., Elliott B.M., and Grunberg N.E. Adult vs. adolescent rats differ in biobehavioral responses to chronic nicotine administration. Pharmacol. Biochem. Behav. 70 (2001) 475-489
21. Fewell J.E., Smith F.G., and Ng V.K.Y. Threshold levels of maternal nicotine impairing protective responses of newborn rats to intermittent hypoxia. J. Appl. Physiol. 90 (2001) 1968-1976
22. Fujita M., Charney D.S., and Innis R.B. Imaging serotonergic neurotransmission in depression: hippocampal pathophysiology may mirror global brain alterations. Biol. Psychiatr. 48 (2000) 801-812
23. Goodman E., and Capitman J. Depressive symptoms and cigarette smoking among teens. Pediatrics 106 (2000) 748-755
24. Hellstrom-Lindahl E., and Nordberg A. Smoking during pregnancy: a way to transfer the addiction to the next generation?. Respiration 69 (2002) 289-293
25. Hohmann C.F. A morphogenetic role for acetylcholine in mouse cerebral neocortex. Neurosci. Biobehav. Rev. 27 (2003) 351-363
26. Hohmann C.F., and Berger-Sweeney J. Cholinergic regulation of cortical development and plasticity: new twists to an old story. Perspect. Dev. Neurobiol. 5 (1998) 401-425
27. Isaac P.F., and Rand M.J. Cigarette smoking and plasma levels of nicotine. Nature 236 (1972) 308-310
28. Jacobsen L.K., Slotkin T.A., Westerveld M., Mencl W.E., and Pugh K.R. Visuospatial memory deficits during nicotine withdrawal in adolescents with prenatal exposure to active maternal smoking. Neuropsychopharmacology 31 (2006) 1550-1561
29. Kandel D.B., Wu P., and Davies M. Maternal smoking during pregnancy and smoking by adolescent daughters. Am. J. Public Health 84 (1994) 1407-1413
30. Lauder J.M., and Schambra U.B. Morphogenetic roles of acetylcholine. Environ. Health Perspect. 107 Suppl. 1 (1999) 65-69
31. Levin E.D., and Slotkin T.A. Developmental neurotoxicity of nicotine. In: Slikker W., and Chang L.W. (Eds). Handbook of Developmental Neurotoxicology (1998), Academic Press, San Diego 587-615
32. Levin E.D., Lawrence S., Petro A., Horton K., Seidler F.J., and Slotkin T.A. Increased nicotine self-administration following prenatal exposure in female rats. Pharmacol. Biochem. Behav. 85 (2006) 669-674
33. 2 receptor binding sites: binding properties, brain distribution, and functional role. Mol. Pharmacol. 21 (1982) 301-314
34. Lichtensteiger W., Ribary U., Schlumpf M., Odermatt B., and Widmer H.R. Prenatal adverse effects of nicotine on the developing brain. Prog. Brain Res. 73 (1988) 137-157
35. Maes M., and Meltzer H. The serotonin hypothesis of major depression. In: Bloom F.E., Kupfer D.J., Bunney B.S., Ciaranello R.D., Davis K.L., Koob G.F., Meltzer H.Y., Schuster C.R., Shader R.I., and Watson S.J. (Eds). Psychopharmacology: The Fourth Generation of Progress (1995), Raven Press, New York 933-944
36. Martini S., Wagner F.A., and Anthony J.C. The association of tobacco smoking and depression in adolescence: evidence from the United States. Subst. Use Misuse 37 (2002) 1853-1867
37. Meister B., Johnson H., and Ulfhake B. Increased expression of serotonin transporter messenger RNA in raphe neurons of the aged rat. Mol. Brain Res. 33 (1995) 87-96
38. Meyer A., Seidler F.J., Aldridge J.E., Tate C.A., Cousins M.M., and Slotkin T.A. Critical periods for chlorpyrifos-induced developmental neurotoxicity: alterations in adenylyl cyclase signaling in adult rat brain regions after gestational or neonatal exposure. Environ. Health Perspect. 112 (2004) 295-301
39. Meyer A., Seidler F.J., Cousins M.M., and Slotkin T.A. Developmental neurotoxicity elicited by gestational exposure to chlorpyrifos: when is adenylyl cyclase a target?. Environ Health Perspect. 111 (2003) 1871-1876
40. Meyer A., Seidler F.J., and Slotkin T.A. Developmental effects of chlorpyrifos extend beyond neurotoxicity: critical periods for immediate and delayed-onset effects on cardiac and hepatic cell signaling. Environ. Health Perspect. 112 (2004) 170-178
41. Morin D., Sapena R., Zini R., and Tillement J.P. Serotonin enhances the β-adrenergic response in rat brain cortical slices. Eur. J. Pharmacol. 225 (1992) 273-274
42. Murrin L.C., Ferrer J.R., and Zeng W. Nicotine administration during pregnancy and its effect on striatal development. Neurosci. Abs. 11 (1985) 69
43. Nestler E.J. Molecular mechanisms of drug addiction. J. Neurosci. 12 (1992) 2439-2450
44. Niaura R., Bock B., Lloyd E.E., Brown R., Lipsitt L.P., and Buka S. Maternal transmission of nicotine dependence: psychiatric, neurocognitive and prenatal factors. Am. J. Addict. 10 (2001) 16-29
45. 2A receptors and 5-HT transporters in diet-induced obese rats. Brain Res. 847 (1999) 90-97
46. Patten C.A., Choi W.S., Gillin J.C., and Pierce J.P. Depressive symptoms and cigarette smoking predict development and persistence of sleep problems in US adolescents. Pediatrics 106 (2000) 50-58
47. Porath A.J., and Fried P.A. Effects of prenatal cigarette and marijuana exposure on drug use among offspring. Neurotoxicol. Teratol. 27 (2005) 267-277
48. 1A agonist 8-OH-DPAT. Psychopharmacology 133 (1997) 343-346
49. 1A receptor: G protein coupling and signalling pathways. Br. J. Pharmacol. 127 (1999) 1751-1764
50. Ribary U., and Lichtensteiger W. Effects of acute and chronic prenatal nicotine treatment on central catecholamine systems of male and female rat fetuses and offspring. J. Pharmacol. Exp. Ther. 248 (1989) 786-792
51. Roberts K.H., Munafò M.R., Rodriguez D., Drury M., Murphy M.F.G., Neale R.E., and Nettle D. Longitudinal analysis of the effect of prenatal nicotine exposure on subsequent smoking behavior of offspring. Nicotine Tobacco Res. 7 (2005) 801-808
52. Rovescalli A.C., Brunello N., Perez J., Vitali S., Steardo L., and Racagni G. Heterologous sensitization of adenylate cyclase activity by serotonin in the rat cerebral cortex. Eur. Neuropsychopharmacol. 3 (1993) 463-475
53. Salin-Pascual R.J., De la Fuente J.R., Galicia-Polo L., and Drucker-Colin R. Effects of transdermal nicotine on mood and sleep in nonsmoking major depressed patients. Psychopharmacology 121 (1995) 476-479
54. Seamon K.B., and Daly J.W. Forskolin its biological chemical properties. Adv. Cyclic Nucleotide Protein Phosphorylation Res. 20 (1986) 1-150
55. Slikker W., Xu Z.A., Levin E.D., and Slotkin T.A. Mode of action: disruption of brain cell replication, second messenger, and neurotransmitter systems during development leading to cognitive dysfunction - developmental neurotoxicity of nicotine. Crit. Rev. Toxicol. 35 (2005) 703-711
56. Slotkin T.A. Prenatal exposure to nicotine: What can we learn from animal models?. In: Zagon I.S., and Slotkin T.A. (Eds). Maternal Substance Abuse and the Developing Nervous System (1992), Academic Press, San Diego 97-124
57. Slotkin T.A. Fetal nicotine or cocaine exposure: which one is worse?. J. Pharmacol. Exp. Ther. 285 (1998) 931-945
58. Slotkin T.A. Developmental cholinotoxicants: nicotine and chlorpyrifos. Environ. Health Perspect. 107 Suppl. 1 (1999) 71-80
59. Slotkin T.A. Nicotine and the adolescent brain: insights from an animal model. Neurotoxicol. Teratol. 24 (2002) 369-384
60. Slotkin T.A. Cholinergic systems in brain development and disruption by neurotoxicants: nicotine, environmental tobacco smoke, organophosphates. Toxicol. Appl. Pharmacol. 198 (2004) 132-151
61. Slotkin T.A., and Seidler F.J. A unique role for striatal serotonergic systems in the withdrawal from adolescent nicotine administration. Neurotoxicol. Teratol. 29 (2007) 10-16
62. Slotkin T.A., Cousins M.M., Tate C.A., and Seidler F.J. Serotonergic cell signaling in an animal model of aging and depression: olfactory bulbectomy elicits different adaptations in brain regions of young adult versus aging rats. Neuropsychopharmacology 30 (2005) 52-57
63. Slotkin T.A., Epps T.A., Stenger M.L., Sawyer K.J., and Seidler F.J. Cholinergic receptors in heart and brainstem of rats exposed to nicotine during development: implications for hypoxia tolerance and perinatal mortality. Dev. Brain Res. 113 (1999) 1-12
64. Slotkin T.A., MacKillop E.A., Rudder C.L., Ryde I.T., Tate C.A., and Seidler F.J. Permanent, sex-selective effects of prenatal or adolescent nicotine exposure, separately or sequentially, in rat brain regions: indices of cholinergic and serotonergic synaptic function, cell signaling, and neural cell number and size at six months of age. Neuropsychopharmacology 32 (2007) 1082-1097
65. Slotkin T.A., Miller D.B., Fumagalli F., McCook E.C., Zhang J., Bissette G., and Seidler F.J. Modeling geriatric depression in animals: biochemical and behavioral effects of olfactory bulbectomy in young versus aged rats. J. Pharmacol. Exp. Ther. 289 (1999) 334-345
66. Slotkin T.A., Tate C.A., Cousins M.M., and Seidler F.J. Prenatal nicotine exposure alters the response to subsequent nicotine administration and withdrawal in adolescence: serotonin receptors and cell signaling. Neuropsychopharmacology 31 (2006) 2462-2475
67. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., and Klenk D.C. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150 (1985) 76-85
68. Snedecor G.W., and Cochran W.G. Statistical Methods (1967), Iowa State University Press, Ames, Iowa
69. Stockmeier C.A., Shapiro L.A., Dilley G.E., Kolli T.N., Friedman L., and Rajkowska G. Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression: postmortem evidence for decreased serotonin activity. J. Neurosci. 18 (1998) 7394-7401
70. Suemaru K., Araki H., Kitamura Y., Yasuda K., and Gomita Y. Cessation of chronic nicotine administration enhances wet-dog shake responses to 5-HT2 receptor stimulation in rats. Psychopharmacology 159 (2001) 38-41
71. Suzuki S., Brown C.M., and Wise P.M. Mechanisms of neuroprotection by estrogen. Endocrine 29 (2006) 209-215
72. Trauth J.A., Seidler F.J., and Slotkin T.A. An animal model of adolescent nicotine exposure: effects on gene expression and macromolecular constituents in rat brain regions. Brain Res. 867 (2000) 29-39
73. Tsoh J.Y., Humfleet G.L., Munoz R.F., Reus V.I., Hartz D.T., and Hall S.M. Development of major depression after treatment for smoking cessation. Am. J. Psychiat. 157 (2000) 368-374
74. Tzavara E.T., Monory K., Hanoune J., and Nomikos G.G. Nicotine withdrawal syndrome: behavioural distress and selective up-regulation of the cyclic AMP pathway in the amygdala. Eur. J. Neurosci. 16 (2002) 149-153
75. Wakschlag L.S., Pickett K.E., Cook E., Benowitz N.L., and Leventhal B.L. Maternal smoking during pregnancy and severe antisocial behavior in offspring: a review. Am. J. Public Health 92 (2002) 966-974
76. Weissman M.M., Warner V., Wickramaratne P.J., and Kandel D.B. Maternal smoking during pregnancy and psychopathology in offspring followed to adulthood. J. Am. Acad. Child Adolesc. Psychiatr. 38 (1999) 892-899
77. Weitzman M., Byrd R.S., Aligne C.A., and Moss M. The effects of tobacco exposure on children's behavioral and cognitive functioning: implications for clinical and public health policy and future research. Neurotoxicol. Teratol. 24 (2002) 397-406
78. Wu L.T., and Anthony J.C. Tobacco smoking and depressed mood in late childhood and early adolescence. Am. J. Public Health 89 (1999) 1837-1840
79. Xu Z., Seidler F.J., Ali S.F., Slikker W., and Slotkin T.A. Fetal and adolescent nicotine administration: effects on CNS serotonergic systems. Brain Res. 914 (2001) 166-178
80. Xu Z., Seidler F.J., Cousins M.M., Slikker W., and Slotkin T.A. Adolescent nicotine administration alters serotonin receptors and cell signaling mediated through adenylyl cyclase. Brain Res. 951 (2002) 280-292
81. 2 receptors. Naunyn-Schmiedebergs Arch. Pharmacol. 366 (2002) 276-281
82. Yatham L.N., Liddle P.F., Dennie J., Shiah I.S., Adam M.J., Lane C.J., Lam R.W., and Ruth T.J. Decrease in brain serotonin-2 receptor binding in patients with major depression following desipramine treatment: a positron emission tomography study with fluorine-18-labeled setoperone. Arch. Gen. Psychiat. 56 (1999) 705-711
83. Yatham L.N., Liddle P.F., Shiah I.S., Scarrow G., Lam R.W., Adam M.J., Zis A.P., and Ruth T.J. Brain serotonin-2 receptors in major depression: a positron emission tomography study. Arch. Gen. Psychiat. 57 (2000) 850-858